Kelly Gold

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Josh Mandel-Brehm, as Attorney-in-Fact
Transaction view
Report rows are grouped by the transaction date disclosed in the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Holdings reported by Kelly Gold:

Form 4 holding Chief Financial Officer

Camp4 Therapeutics Corp

Security class
Stock Option (Right to Buy)
Shares / value
215,000
Estimated value
Report date
01 Apr 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Kelly Gold

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .